Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
7
×
biotech
cancer
7
×
life sciences
national blog main
san diego blog main
san diego top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
pfizer
deals
merck
biontech
bristol-myers squibb
clinical trials
eli lilly
gene editing
glaxosmithkline
hepatitis b
medicare
What
bio
7
×
roundup
buy
cancer
drug
moves
patients
pharmaceutical
abbvie’s
acquisitions
advantages
alliance
appetite
approved
bar
barbecuing
becker
biggest
billions
black
bread
brings
bristol
build
butter
buyout
calls
camping
cardiologist
cash
center
ceo
changing
check
cholesterol
color
combo
companies
company’s
conference
Language
unset
Current search:
cancer
×
bio
×
amgen
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More